OWH

Ovia Health Recognized by HHS for Program to Improve Birth Equity

Retrieved on: 
Tuesday, September 13, 2022

BOSTON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Ovia Health, the most trusted digital women’s and family health solution, has been recognized by the U.S. Department of Health and Human Services (HHS) for its work to deepen Ovia’s reach in addressing inequities in postpartum care for Black or African American (AA) and American Indian (AI) or Alaska Native (AN) Medicaid or Children’s Health Insurance Program (CHIP) beneficiaries. The company was recently selected as a Phase 1 winner in the HHS Racial Equity in Postpartum Care Challenge, enabling Ovia to continue expanding its existing programming to reach even more of these individuals.

Key Points: 
  • The company was recently selected as a Phase 1 winner in the HHS Racial Equity in Postpartum Care Challenge , enabling Ovia to continue expanding its existing programming to reach even more of these individuals.
  • As a leader in family health and birth equity, we are committed to shining a much needed spotlight on low-income women of color, one of our countrys most vulnerable populations, said Ovia Health Chief Medical Officer Dr. Leslie Saltzman.
  • By participating in the HHS Challenge, were working to bring attention to the disparities of this population and get them the care they need and deserve.
  • Ovia Health is the only family health solution clinically proven to effectively identify and intervene with high-risk conditions.

The Worldwide Assisted Reproductive Technology Industry is Expected to Reach $12 + Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 17, 2021

The "Assisted Reproductive Technology Market by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Assisted Reproductive Technology Market by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global assisted reproductive technology market was valued at $2,317.7 million in 2020, and is estimated to reach $12,272.5 million by 2030, growing at a CAGR of 19.3% from 2021 to 2030.
  • Assisted reproductive technology (ART) is defined as the medical procedure used to address the infertility treatments for handling of eggs and embryo.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global assisted reproductive technology market.